BUB
VAR

BBVA USA Bancshares’s Varian Medical Systems, Inc. VAR Stock Holding History

BBVA USA Bancshares’s Portfolio VAR Stock Details VAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$2.79M Sell
15,824
-5,209
-25% -$917K 0.13% 158
2020
Q4 		$3.68M Sell
21,033
-5,163
-20% -$895K 0.19% 124
2020
Q3 		$4.47M Sell
26,196
-2,675
-9% -$421K 0.26% 96
2020
Q2 		$3.54M Sell
28,871
-2,583
-8% -$299K 0.21% 110
2020
Q1 		$3.23M Sell
31,454
-3,909
-11% -$516K 0.23% 105
2019
Q4 		$5.02M Sell
35,363
-5,688
-14% -$726K 0.29% 88
2019
Q3 		$4.89M Sell
41,051
-3,099
-7% -$369K 0.32% 88
2019
Q2 		$6.01M Buy
44,150
+29
+0.1% +$3.88K 0.36% 67
2019
Q1 		$6.25M Sell
44,121
-685
-2% -$90K 0.39% 62
2018
Q4 		$5.08M Sell
44,806
-2,723
-6% -$311K 0.36% 69
2018
Q3 		$5.32M Sell
47,529
-1,188
-2% -$134K 0.32% 78
2018
Q2 		$5.54M Sell
48,717
-1,752
-3% -$210K 0.35% 74
2018
Q1 		$6.19M Sell
50,469
-1,638
-3% -$195K 0.4% 63
2017
Q4 		$5.79M Sell
52,107
-2,049
-4% -$220K 0.37% 67
2017
Q3 		$5.42M Sell
54,156
-1,140
-2% -$117K 0.35% 74
2017
Q2 		$5.71M Sell
55,296
-37
-0.1% -$3.56K 0.38% 67
2017
Q1 		$5.04M Sell
55,333
-11,262
-17% -$939K 0.34% 74
2016
Q4 		$5.24M Buy
66,595
+191
+0.3% +$15.5K 0.37% 68
2016
Q3 		$5.79M Buy
66,404
+60
+0.1% +$4.89K 0.42% 62
2016
Q2 		$4.78M Buy
66,344
+2,954
+5% +$214K 0.36% 72
2016
Q1 		$4.45M Buy
63,390
+11,943
+23% +$811K 0.34% 73
2015
Q4 		$3.65M Sell
51,447
-3,841
-7% -$265K 0.27% 98
2015
Q3 		$3.58M Buy
55,288
+2,425
+5% +$177K 0.28% 97
2015
Q2 		$3.91M Buy
52,863
+4,242
+9% +$332K 0.22% 119
2015
Q1 		$4.01M Buy
48,621
+5,978
+14% +$480K 0.18% 150
2014
Q4 		$3.23M Buy
42,643
+6,015
+16% +$448K 0.15% 161
2014
Q3 		$2.57M Buy
36,628
+23,666
+183% +$1.74M 0.11% 174
2014
Q2 		$945K Sell
12,962
-227
-2% -$16.3K 0.04% 285
2014
Q1 		$972K Sell
13,189
-1,124
-8% -$80.9K 0.04% 269
2013
Q4 		$975K Sell
14,313
-5,165
-27% -$344K 0.04% 267
2013
Q3 		$1.28M Sell
19,478
-21,231
-52% -$1.34M 0.06% 230
2013
Q2 		$2.41M Buy
+40,709
New +$2.44M 0.12% 180

Other funds holding VAR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
PAM
PSquared Asset Management Zurich, Switzerland $287M AUM 58.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BBVA USA Bancshares's VAR Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Varian Medical Systems, Inc. (VAR) stake by 25% in Q1 2021, selling an estimated $917K and leaving 15,824 shares worth $2.79M. The position accounts for 0.13% of the portfolio, ranked #158.

BBVA USA Bancshares first reported a position in VAR in Q2 2013 and has held it in 32 quarters since. The position peaked at $6.25M in Q1 2019. 600 funds tracked by Wall St. Rank hold VAR as of Q1 2021.

  • BBVA USA Bancshares held 15,824 shares of Varian Medical Systems, Inc. worth $2.79M as of Q1 2021.
  • BBVA USA Bancshares sold 5,209 Varian Medical Systems, Inc. shares in Q1 2021, an estimated $917K.
  • Varian Medical Systems, Inc. made up 0.13% of BBVA USA Bancshares's portfolio in Q1 2021, its #158 holding.
  • BBVA USA Bancshares first reported a position in Varian Medical Systems, Inc. in Q2 2013 and has held it in 32 quarters since.
  • BBVA USA Bancshares's Varian Medical Systems, Inc. position peaked at $6.25M in Q1 2019.
  • 600 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.